Correlation Between BioArctic and ExpreS2ion Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioArctic and ExpreS2ion Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioArctic and ExpreS2ion Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioArctic AB and ExpreS2ion Biotech Holding, you can compare the effects of market volatilities on BioArctic and ExpreS2ion Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioArctic with a short position of ExpreS2ion Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioArctic and ExpreS2ion Biotech.

Diversification Opportunities for BioArctic and ExpreS2ion Biotech

-0.34
  Correlation Coefficient

Very good diversification

The 3 months correlation between BioArctic and ExpreS2ion is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding BioArctic AB and ExpreS2ion Biotech Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ExpreS2ion Biotech and BioArctic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioArctic AB are associated (or correlated) with ExpreS2ion Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ExpreS2ion Biotech has no effect on the direction of BioArctic i.e., BioArctic and ExpreS2ion Biotech go up and down completely randomly.

Pair Corralation between BioArctic and ExpreS2ion Biotech

Assuming the 90 days trading horizon BioArctic AB is expected to under-perform the ExpreS2ion Biotech. But the stock apears to be less risky and, when comparing its historical volatility, BioArctic AB is 3.44 times less risky than ExpreS2ion Biotech. The stock trades about -0.03 of its potential returns per unit of risk. The ExpreS2ion Biotech Holding is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  16,681  in ExpreS2ion Biotech Holding on September 2, 2024 and sell it today you would lose (14,596) from holding ExpreS2ion Biotech Holding or give up 87.5% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

BioArctic AB  vs.  ExpreS2ion Biotech Holding

 Performance 
       Timeline  
BioArctic AB 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in BioArctic AB are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, BioArctic sustained solid returns over the last few months and may actually be approaching a breakup point.
ExpreS2ion Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ExpreS2ion Biotech Holding has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

BioArctic and ExpreS2ion Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioArctic and ExpreS2ion Biotech

The main advantage of trading using opposite BioArctic and ExpreS2ion Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioArctic position performs unexpectedly, ExpreS2ion Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ExpreS2ion Biotech will offset losses from the drop in ExpreS2ion Biotech's long position.
The idea behind BioArctic AB and ExpreS2ion Biotech Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges